We are live on ! Find out more
Hudson Bay Capital Management

Hudson Bay Capital Management Portfolio holdings

AUM $29B
1-Year Est. Return 30.2%
This Fund
S&P 500
This Quarter Est. Return
+23.54%
1 Year Est. Return
+30.2%
3 Year Est. Return
+99.99%
5 Year Est. Return
+135.78%
10 Year Est. Return
+498.47%
AUM
$5.72B
AUM Growth
+$1.72B
Cap. Flow
-$1.08B
Cap. Flow %
-18.95%
Top 10 Hldgs %
42.77%
Holding
683
New
195
Increased
120
Reduced
90
Closed
196

Top Buys

Rank Stock Value
1
LEGN icon
Legend Biotech
LEGN
+$119M
2
DKNG icon
DraftKings
DKNG
+$63.9M
3
NKLA
Nikola Corporation Common Stock
NKLA
+$49.9M
4
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$45.5M
5
CTEV
Claritev Corp
CTEV
+$42.4M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$187M
2
CCXX.U
Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt
CCXX.U
+$43.2M
3
TSLA icon
Tesla
TSLA
+$38.7M
4
AMZN icon
Amazon
AMZN
+$37M
5
CFFAU
CF Finance Acquisition Corp. Unit
CFFAU
+$27M

Sector Composition

Rank Sector Weight
1 Healthcare 13.08%
2 Communication Services 9.75%
3 Consumer Discretionary 8.87%
4 Financials 5.61%
5 Industrials 3.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XBI icon
76
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$10.6M 0.19%
+94,500
New +$9.31M
RARE icon
77
Ultragenyx Pharmaceutical
RARE
$2.64B
$10.6M 0.18%
135,000
-98,706
-42% -$6.53M
JWS.U
78
DELISTED
Jaws Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of one red
JWS.U
$10.4M 0.18%
+1,000,000
New +$10.4M
SNAX
79
DELISTED
Stryve Foods, Inc. Class A Common Stock
SNAX
$10.3M 0.18%
66,624
+65,200
+4,579% +$9.98M
CHE icon
80
Chemed
CHE
$7.18B
$10.1M 0.18%
22,500
+20,000
+800% +$8.93M
CB icon
81
Chubb
CB
$134B
$10.1M 0.18%
+80,000
New +$9.27M
GS icon
82
Goldman Sachs
GS
$301B
$9.88M 0.17%
+50,000
New +$9.39M
JPM icon
83
JPMorgan Chase
JPM
$956B
$9.88M 0.17%
105,000
+55,000
+110% +$5.22M
LPLA icon
84
LPL Financial
LPLA
$29.3B
$9.8M 0.17%
+125,000
New +$8.35M
TRIT
85
DELISTED
Triterras, Inc. Class A Ordinary Shares
TRIT
$9.78M 0.17%
909,768
+625,200
+220% +$6.26M
UPH
86
DELISTED
UpHealth, Inc.
UPH
$9.69M 0.17%
95,574
+38,800
+68% +$3.88M
BIDU icon
87
Baidu
BIDU
$37.1B
$9.68M 0.17%
80,745
-49,855
-38% -$5.33M
NXST icon
88
Nexstar Media Group
NXST
$5.91B
$9.56M 0.17%
+114,211
New +$8.59M
PCPL.U
89
DELISTED
CC Neuberger Principal Holdings I Units, each consisting of one Class A ordinary share and one-third
PCPL.U
$9.54M 0.17%
+900,000
New +$9.24M
CFG icon
90
Citizens Financial Group
CFG
$30.6B
$9.46M 0.17%
+375,000
New +$8.51M
ESSC
91
DELISTED
East Stone Acquisition Corporation Ordinary Shares
ESSC
$9.39M 0.16%
951,900
+939,900
+7,833% +$9.16M
SCHW
92
Charles Schwab
SCHW
$188B
$9.28M 0.16%
275,000
+115,000
+72% +$4.12M
BMRN icon
93
BioMarin Pharmaceuticals
BMRN
$13.3B
$9.25M 0.16%
75,000
-10,000
-12% -$994K
EQH icon
94
Equitable Holdings
EQH
$14.4B
$9.16M 0.16%
475,000
+275,000
+138% +$4.91M
MOH icon
95
Molina Healthcare
MOH
$10.4B
$8.9M 0.16%
+50,000
New +$8.51M
GB
96
DELISTED
Global Blue Group Holding
GB
$8.76M 0.15%
855,557
-324,800
-28% -$3.32M
RVPH
97
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$8.71M 0.15%
40,500
– –
BAX icon
98
Baxter International
BAX
$14.4B
$8.61M 0.15%
+100,000
New +$8.71M
TLMD
99
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
$8.61M 0.15%
858,800
– –
KPLT icon
100
Katapult Holdings
KPLT
$31.6M
$8.58M 0.15%
34,500
– –
2 3
4
5 6

Similar funds

Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
State of Tennessee, Department of Treasury
State of Tennessee, Department of Treasury Nashville, Tennessee $29.8B AUM 29.48% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Eagle Capital Management (New York)
Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
TWC
The Woodbridge Company Toronto, Ontario, Canada $27.8B AUM 46.78% 1-Year Est. Return

Hudson Bay Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Hudson Bay Capital Management held 683 positions worth $5.72B, up 43% from $3.99B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Hudson Bay Capital Management withdrew a net $1.08B in Q2 2020, closing 196 positions and reducing 90 holdings. Its most notable exit was Allergan plc, an estimated $187M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Hudson Bay Capital Management opened a new position in Legend Biotech worth $122M.

  • Hudson Bay Capital Management's largest Q2 2020 buy was Legend Biotech: 3,056,342 shares worth $122M.
  • Hudson Bay Capital Management added most to DraftKings in Q2 2020, an estimated $63.9M increase.
  • Hudson Bay Capital Management's biggest Q2 2020 reduction was Tesla, cutting an estimated $38.7M.
  • Hudson Bay Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $187M.
  • Hudson Bay Capital Management's ten largest holdings make up 43% of its $5.72B portfolio in Q2 2020.
  • Hudson Bay Capital Management opened 195 new positions and closed 196 in Q2 2020.
  • Hudson Bay Capital Management's portfolio value rose 43% quarter-over-quarter to $5.72B.

Based on Hudson Bay Capital Management's 13F filing for Q2 2020, filed 12 Aug 2020.